Chlorphenacemide
An article about the drug Chlorphenacemide
Chlorphenacemide | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Chlorphenacemide is a pharmaceutical compound that was historically used as a sedative and anticonvulsant. It belongs to the class of carbamate derivatives and was primarily utilized in the mid-20th century for its calming effects on the central nervous system.
Chemical Structure[edit | edit source]
Chlorphenacemide is a carbamate derivative, characterized by its chemical structure which includes a phenyl group attached to a carbamate moiety. The presence of the chlorine atom in its structure is a defining feature that contributes to its pharmacological properties.
Pharmacology[edit | edit source]
Chlorphenacemide acts on the central nervous system to exert its sedative and anticonvulsant effects. It was believed to modulate the activity of neurotransmitters, although the precise mechanism of action was not fully understood at the time of its use. The drug was used to manage conditions such as epilepsy and anxiety disorders.
Medical Uses[edit | edit source]
Chlorphenacemide was primarily prescribed for its sedative properties. It was used to treat patients with seizure disorders, providing relief from convulsions. Additionally, it was sometimes used to alleviate symptoms of anxiety due to its calming effects.
Side Effects[edit | edit source]
The use of Chlorphenacemide was associated with several side effects, which limited its long-term use. Common adverse effects included drowsiness, dizziness, and nausea. In some cases, patients experienced more severe reactions such as allergic reactions or respiratory depression.
Historical Context[edit | edit source]
Chlorphenacemide was developed and used during a period when many new sedative and anticonvulsant drugs were being explored. However, with the advent of more effective and safer alternatives, its use declined. The development of benzodiazepines and other anticonvulsants offered better therapeutic profiles, leading to the eventual discontinuation of Chlorphenacemide in clinical practice.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD